The purpose of this work is to evaluate the HYPERSCINT HS-RP100 scintillation dosimetry research platform designed for clinical quality assurance (QA) for use in in vivo dosimetry measurements. The device correctly detected the treatment error when the heads were intentionally laterally shifted. In three canine clinical patients treated in multiple fractions.
J Appl Clin Med Phys. 2022
I.Schoepper (1), S.Dieterich (2), E.Alonzo Trestrail (3), M.Sean Kent (1) | Department of Radiation Oncology, University of California Davis School of Veterinary Medicine, Davis, California, USA, Department of Radiation Oncology, University of California Davis, Medical Center, Sacramento, California, USA, Pacific Crest Medical Physics, Chico, California, USA